Author

K. Yonemitsu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

H. Asakura· 2 shared A. Nishimura· 1 shared A. Satsuka· 1 shared D. Tomokiyo· 1 shared J. M. Lee· 1 shared K. Mizuguchi· 1 shared K. Nishiyama· 1 shared K. Tateda· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

H. Asakura

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry

Y. Kato, S. Yamada, K. Nishiyama, A. Satsuka, S. Re, D. Tomokiyo, J. M. Lee, T. Tanaka, A. Nishimura, K. Yonemitsu, H. Asakura, Y. Ibuki, Y. Imai, N. Kamiya, K. Mizuguchi, , M. Nishida

This study shows clomipramine inhibits SARS-CoV-2 entry into cardiomyocytes and synergizes with remdesivir to suppress infection.

bioRxiv · Mar 13, 2021 · PreprintPharmacology & Toxicology

Photocatalyst under visible light irradiation inactivates SARS-CoV-2 on an abiotic surface

M. Uema, K. Yonemitsu, Y. Momose, Y. Ishii, K. Tateda, T. Inoue, H. Asakura

This study shows that a visible light-responsive photocatalyst inactivates SARS-CoV-2 on surfaces under specific conditions, reducing viral titers and spike protein levels.

bioRxiv · Nov 1, 2020 · PreprintMicrobiology